Increased circulating soluble LR11 in patients with acute coronary syndrome

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 191-194

  Ogita, Manabu ^a   Miyauchi, Katsumi ^a   Dohi, Tomotaka ^a   Tsuboi, Shuta ^a   Miyazaki, Tadashi ^a   Yokoyama, Takayuki ^a   Yokoyama, Ken ^a   Shimada, Kazunori ^a   Kurata, Takeshi ^a   Jiang, Meizi ^b   Bujo, Hideaki ^b   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acute coronary syndrome; Biomarker; Smooth muscle cell

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CIRCULATING SOLUBLE LR11; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; VASCULAR SMOOTH MUSCLE;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION;

ANGINA;

EID: 84869101747     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.047     Document Type: Article

References (26)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
2. Fox K.A., Cokkinos D.V., Deckers J., et al. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000, 21:1440-1449.
3. WHO MONICA Project Principal Investigators The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): major international collaboration. J Clin Epidemiol 1988, 41:105-114.
4. Fuster V., Badimon L., Badimon J.J., et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992, 326(242-250):310-318.
5. Waxman S., Ishibashi F., Muller J.E. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 2006, 114:2390-2411.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
7. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
8. Kanaki T., Bujo H., Hirayama S., et al. Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999, 19:2687-2695.
9. Zhu Y., Bujo H., Yamazaki H., et al. LR11, an LDL receptor gene family, is a novel regulator of smooth muscle cell migration. Circ Res 2004, 94:752-758.
10. Zhu Y., Bujo H., Yamazaki H., et al. Enhanced expression of the LDL receptor family member LR11 increases migration of smooth muscle cells in vitro. Circulation 2002, 105:1830-1836.
11. Jiang M., Bujo H., Ohwaki K., et al. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice. J Clin Invest 2008, 118:2733-2746.
12. Matsuo M., Ebinuma H., Fukamachi I., et al. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis. Clin Chem 2009, 55:1801-1808.
13. Takahashi M., Bujo H., Jiang M., et al. Enhanced circulating soluble LR11 in patients with coronary organic stenosis. Atherosclerosis 2010, 210:581-584.
14. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-C12.
15. Galis Z.S., Sukhova G.K., Lark M.W., et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
16. Schwartz S.M., Galis Z.S., Rosenfeld M.E., et al. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007, 4:705-713.
17. Shar P.K., Falk E., Badimon J.J., et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
18. Fukuda D., Masanori A. Intimal smooth muscle cells. The context-dependent origin. Circulation 2010, 122:2005-2008.
19. Jiang M., Bujo H., Zhu Y., et al. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells. Biochem Biophys Res Commun 2006, 348:1367-1377.
20. Calabro P., Willerson J.T., Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930-1932.
21. Ohwaki K., Bujo H., Jiang M., et al. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler Thromb Vasc Biol 2007, 27:1050-1056.
22. May A.E., Schmidt R., Kanse S.M., et al. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 2002, 100:3611-3617.
23. Blasi F., Carmeliet P. uPAR: versatile signaling orchestrator. Nat Rev Mol Cell Biol 2002, 3:932-943.
24. Xu J., Li W., Bao X., et al. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction. Clin Sci (Lond) 2010, 119:353-359.
25. Cozen A.E., Moriwaki H., Kremen M., et al. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 2004, 109:2129-2135.
26. Svensson P.A., Olson F.J., Hagg D.A., et al. Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis. Int J Mol Med 2008, 22:459-464.